Epimastigotes treated with 0.1mM for different time (h) (× 10*6)  
Compound 0 24 48 72 96 120
1 2.0 ± 0.1 2.1 ± 0.1 2.0 ± 0.1 1.5 ± 0.1 1.4 ± 0.1 1.1 ± 0.1
2 2.0 ± 0.1 4.3 ± 0.1 6.9 ± 0.1 9.1± 0.1 9.8± 0.1 13.5 ± 4.9
3 1.8 ± 0.1 2.6 ± 0.3 5.3 ± 0.1 14.4 ± 0.4 18 ± 1.4 15.5 ± 0.7
4 1.9 ± 0.1 1.8 ± 0.1 4.2 ± 0.5 8.6 ± 0.4 24.3 ± 0.6 25.5 ± 0.7
5 1.7 ± 0.2 2.3 ± 0.1 3.6 ± 1 4.3 ± 0.1 5.8 ± 0.1 7.9 ± 0.1
6 2.2 ± 0.1 2.9 ± 0.3 2 ± 0.8 2.5 ± 0.2 1.6 ± 0.4 1.5 ± 0.5
7 1.9 ± 0.2 2.6 ± 0.1 2.9 ± 1.1 3.5 ± 0.6 5.2 ± 0.4 6.3 ± 0.4
8 1.95 ± 0.2 2.65 ± 0.9 2.45 ± 0.3 3.05 ± 0.1 3.45 ± 0.1 3.65 ± 0.1
9 2.1 ± 0.1 2.7 ± 0.4 2 ± 0 2 ± 0.1 1.4 ± 0.1 1.4 ± 0.3
10 1.9 ± 0.2 2.8 ± 0.3 2.9 ± 1 4.9 ± 0.1 7.3 ± 0.2 7.8 ± 0.2
11 1.9 ± 0.2 2.8 ± 0.3 3.1 ± 0.8 4.7 ± 0.3 7.2± 0.3 8.3 ± 0.9
12 1.9 ± 0.2 3.3 ± 0.3 3.2 ± 1 5.2 ± 1 7.2± 0.4 8.3 ± 0.9
13 2.2 ± 0.1 3 ± 0.1 2 ± 0.8 2.2 ± 0.2 1.4 ± 0.1 1.1 ± 0.1
14 2 ± 0.3 2.3 ± 0.3 4.1 ± 0.1 6.2 ± 0.3 5.1 ± 0.2 3.4 ± 0.6
HU 3.2 ± 0.1 6.0 ± 0.8 10.9 ± 0.6 21.8 ± 1.2 33.7 ± 1.8 46.7 ± 0.8
BZD 2.1 ± 0.1 2.0 ± 0.1 0.7 ± 0.1 0 0 0
Table 2: Treatment of epimastigotes of T. cruzi with 0.1 mM of compounds using different time incubation. Values are mean ± SD (n=3).